Learn More
Invitrogen™ SARS-CoV-2 Nucleocapsid Recombinant Human Monoclonal Antibody (RMH03)
Human Recombinant Monoclonal Antibody
Supplier: Invitrogen™ MA538681
Description
This antibody is a Human-Rabbit chimeric antibody, made by fusion of the antigen binding region (variable domains of the heavy and light chains, VH and VL) of a rabbit anti-NP (2019-nCov) monoclonal antibody, with the constant domain of Human IgG1. This antibody is recognized only by an anti-Human IgG secondary antibody.
SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. The SARS-CoV-2 N protein is an abundant RNA-binding protein critical for viral genome packaging, yet the molecular details that involve this process are poorly understood. N protein contains three dynamic disordered regions that house putative transiently-helical binding motifs. The two folded domains interact minimally such that full-length N protein is a flexible and multivalent RNA-binding protein. SARS-CoV-2 causes illnesses ranging from the common cold to severe diseases.
Specifications
SARS-CoV-2 Nucleocapsid | |
Recombinant Monoclonal | |
1 mg/mL | |
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide | |
P0DTC9 | |
N | |
A recombinant 2019-nCov Nucleocapsid Protein expressed in E. coli. | |
100 μg | |
Primary | |
Virus | |
Antibody | |
IgG1 |
ELISA | |
RMH03 | |
Unconjugated | |
N | |
COVID19 Nucleocapsid; COVID-19 nucleocapsid; COVID19 Spike nucleocapsid; SARS-CoV-2 N | |
Human | |
Protein A | |
RUO | |
43740575 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.